(Date:11/24/2009)...York investment bank KTA Capital,s client Neuren P...mil convertible note private placement with a U.S.... arranged by KTA Capital as Neuren,s exclusive pla... New York (PRWEB) November 23, 2009 -- The indep..."KTA Capital") has announced that its cl...
(Date:11/24/2009)...-FirstCall/--Sigma-AldrichCorporation(Nasdaq: SIAL...y,December1stat1:45PMGMTinLondon,7:45AMUS/CST.Inte...Internetavailableat http://inve s tor.sig m a...accessthisfile. ,, AboutSigma-Aldrich: Sigma...any.Itschemicalandbiochemicalproductsandkitsareuse...
(Date:11/24/2009)...ewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),...mercializingnovelpainmanagementtherapies,announced...Officer,isscheduledtopresentatthe21stAnnualPiperJa...atTheNewYorkPalaceHotelinNewYork,NewYork. ,, Mr...willbeavailabletorespondtoquestionsduringthepresen...
(Date:11/24/2009)...beenmetforpatientswithadvanced-stage,orrecurrenten...re-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TS...nyfocusedonendocrinetherapyandoncology,todayannoun...etedcytotoxicpeptideconjugate,AEZS-108(formerlyAN-...ancer.Inapersonalizedhealthcareapproach,thestudyse...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4...upport doubled to take product ideas to market, R...ech companies may qualify for up to $1 million in ...rth Carolina Biotechnology Center., The loans are...nology,Center for companies in North Carolina. The...hey become competitive for angel or,venture-capita...
... First sales for revoluti...e Ovalum Ltd., a privately held Israeli medical de...les of its new CiTop™ Guidewire product-line...culature. The devices are intended to assist in t... (CTO). These obstructions are hard to traverse an...
...mong top 10 most promising drugs ...PRNewswire-FirstCall/ - Resverlogix Corp,s,("Resve...A-I drug,candidate, RVX-208 has been selected as o...ease (CVD) drugs available for strategic partnerin...er Information, a leading,provider of business inf...
Other Biology Technology:N.C. Biotech Center Launches Larger Loans 2Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe 2Industry Leaders Select Resverlogix's RVX-208 2Industry Leaders Select Resverlogix's RVX-208 3...in the January/February 2007 issue of Physiologica...reveals an unanticipated way freshwater fish may r...ngered naked carp migrate annually between freshwa...n China, where they feed and grow. However, Lake Q... saline--leading to surprising adjustments to the ...
...at the National Institutes of Health have develope...y, eliminate malaria from entire geographic region...a,s mosquitoes. , The vaccine, so far tested only...on who receives it to eliminate the parasite from ..., after the mosquito has fed upon the blood of the...
...pe may predict the survival of corals around the w...rs to come, according to a new model that relies o...e of storms associated with global climate change,...ts on coral reefs, according to a paper published ...Nature. Shape and size of the corals are key varia...
Other Biology News:Climate change has surprising effect on endangered naked carp 2Malaria vaccine prompts victims' immune system to eliminate parasite from mosquitoes 2Malaria vaccine prompts victims' immune system to eliminate parasite from mosquitoes 3Coral reefs are increasingly vulnerable to angry oceans 2Coral reefs are increasingly vulnerable to angry oceans 310% Normal Goat Serum from Invitrogen
Anti-Human IgG, Fd Fragment Monoclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Human VEGF R2 (KDR) Monoclonal Antibody, Unconjugated, Clone 89106 from R&D Systems
Mouse Anti-Salmonella typhimurium Monoclonal Antibody, Unconjugated, Clone 8C11C from ABR-Affinity BioReagents
Biology Products: